Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients Over 52 Weeks
J Invest Dermatol 2018 Nov 30;[EPub Ahead of Print], E von Stebut, K Reich, D Thaçi, W Koenig, A Pinter, A Körber, T Rassaf, A Waisman, V Mani, D Yates, J Frueh, C Sieder, N Melzer, NN Mehta, T GoriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.